← SynDRA
SULTHIAME
SynDRA canonical compound SYN0003727 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | CA12 | CA2 | CA7 | CA9 |
|---|
| Mechanism of action | carbonic anhydrase inhibitor |
|---|
All known targets
- CA2
- CA9
- CA7
- CA12
- CA1
- CA6
- CA
- mtcA1
- ca1
- NCE103
- Ca15
- CA5B
Mechanisms of action (all sources)
- CA2 INHIBITOR
- Carbonic anhydrase inhibitor
- CA7 INHIBITOR
- CA1 INHIBITOR
- CA3 INHIBITOR
- CA6 INHIBITOR
- CA12 INHIBITOR
- CA14 INHIBITOR
- CA9 INHIBITOR
- CA4 INHIBITOR
- CA13 INHIBITOR
- CA5B INHIBITOR
Drug classes
- Anticonvulsants
- Central Nervous System Agents
ATC classes
Cross-references
Synonyms
- sultiame
- sulphenyltame
- sulphenytame
- sulphthiame
- sulthiam
- sulthiamine
- sultiam
- trolone
- Sultiame
- Sultiamo
- RIKER-594
- Conadil
- Ospolot
- Trolone
- Sulphenyltame
- Sulthiamine
- Contravul
- Sultiamum
- Elisal
- Riker 594
- Bayer A-168
- Sultiamum [INN-Latin]
- Sultiamo [INN-Spanish]
- Sulthiame [USAN]
- 4-(1,1-dioxothiazinan-2-yl)benzenesulfonamide
- UNII-I00Q766CZ2
- RP 10284
- R-594
- EINECS 200-511-0
- p-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide, S,S-dioxide
- BRN 1222219
- Benzenesulfonamide, 4-(tetrahydro-2H-1,2-thiazin-2-yl)-, S,S-dioxide
- 4-(1,1-Dioxido-1,2-thiazinan-2-yl)benzenesulfonamide
- CHEMBL328560
- I00Q766CZ2
- DTXCID503626
- RefChem:186763
Look up SULTHIAME in the interactive SynDRA portal →